Impact of rapid multigene assays with short turnaround time (TAT) on the development of precision medicine for non-small cell lung cancer (NSCLC).

Shingo Matsumoto,Takaya Ikeda,Kiyotaka Yoh,Akira Sugimoto,Terufumi Kato,Kei Kunimasa,Atsushi Nakamura,Ichiro Nakachi,Shoichi Kuyama,Jun Sakakibara-Konishi,Haruko Daga,Eiji Iwama,Kageaki Taima,Naoki Furuya,Kaname Nosaki,Hiroki Izumi,Yoshitaka Zenke,Koichi Goto

Impact of rapid multigene assays with short turnaround time (TAT) on the development of precision medicine for non-small cell lung cancer (NSCLC).

2021

Shingo Matsumoto
Takaya Ikeda
Kiyotaka Yoh
Akira Sugimoto
Terufumi Kato
Kei Kunimasa
Atsushi Nakamura
Ichiro Nakachi
Shoichi Kuyama
Jun Sakakibara-Konishi
Haruko Daga
Eiji Iwama
Kageaki Taima
Naoki Furuya
Kaname Nosaki
Hiroki Izumi
Yoshitaka Zenke
Koichi Goto

9094Background: A variety of oncogene drivers have been identified in NSCLC and molecularly-stratified precision medicine has led to improved survival in advanced NSCLC. Next-generation sequencing ...

Keywords:

Precision medicine
Oncology
Internal medicine
Oncogene
Medicine
non-small cell lung cancer (NSCLC)
Turnaround time
improved survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations